A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.

NCT00363025 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

465

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

PROCEDURE: Two post-remission strategies
DRUG: Idarubicin versus daunorubicin

Sponsor

Acute Leukemia French Association

Collaborators

[object Object]